Kelly E. Caudle
Impact in
- Pharmacology top 0.02%
- Pharmacogenetics and Drug Metabolism
-
- Pharmaceutical studies and practices
- Pharmacological Effects and Toxicity Studies
Papers in
- Pharmacology 29
- Pharmacogenetics and Drug Metabolism 29
-
- Pharmaceutical studies and practices 16
- Childhood Cancer Survivors' Quality of Life 3
- Neonatal Health and Biochemistry 3
- Co-authors
- Teri E. KleinMichelle Whirl‐CarrilloMary V. RellingAndrea GaedigkJames M. HoffmanHenry M. DunnenbergerMatthias SchwabJesse J. Swen
- Journals
- Clinical Pharmacology & Therapeutics (27 papers)Genetics in Medicine (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)Pharmacogenomics (2 papers)JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (2 papers)
- Partner nations
- United StatesSpainNetherlands
In The Last Decade
Kelly E. Caudle
54 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Pharmacology 3.1k
- Pediatrics, Perinatology and Child Health 1.7k
- Transplantation 145
- Geriatrics and Gerontology 187
- Pharmacology 786
Countries citing papers authored by Kelly E. Caudle
This map shows the geographic impact of Kelly E. Caudle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly E. Caudle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly E. Caudle more than expected).
Fields of papers citing papers by Kelly E. Caudle
This network shows the impact of papers produced by Kelly E. Caudle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly E. Caudle. The network helps show where Kelly E. Caudle may publish in the future.
Co-authors
The 25 scholars most cited alongside Kelly E. Caudle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 9 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 22 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 28 | |
| 12 | 2019 | 24 | |
| 13 | Abstract 16081: Frequency of Potentially Clinically Relevant Variants of CYP2C19 And SLCO1B1 in a Large Direct-to-Consumer Genetic Database | 2019 | 1 |
| 14 | Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on Hit paper breakdown → | 2018 | 403 |
| 15 | Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update | 2017 | 57 |
| 16 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update Hit paper breakdown → | 2017 | 406 |
| 17 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors | 2015 | 51 |
| 18 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing | 2015 | 63 |
| 19 | Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing. | 2014 | 6 |
| 20 | 2014 | 41 |
About Kelly E. Caudle
Kelly E. Caudle is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health, Anesthesiology and Pain Medicine, Pharmacology and Molecular Medicine, having authored 61 papers that have together received 5.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (29 papers), Pharmaceutical studies and practices (16 papers), Genomics and Rare Diseases (7 papers), Antifungal resistance and susceptibility (6 papers), Colorectal Cancer Treatments and Studies (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Neonatal Health and Biochemistry (3 papers). The work is most often cited by research in Pharmacology (3.1k citations), Pediatrics, Perinatology and Child Health (1.7k citations), Transplantation (145 citations), Geriatrics and Gerontology (187 citations) and Pharmacology (786 citations). Kelly E. Caudle has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include Teri E. Klein, Michelle Whirl‐Carrillo, Mary V. Relling, Andrea Gaedigk, James M. Hoffman, Henry M. Dunnenberger, Matthias Schwab, Jesse J. Swen, Howard L. McLeod and Cyrine E. Haidar. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Genetics in Medicine, Antimicrobial Agents and Chemotherapy, Pharmacogenomics and JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.